| Identification | Back Directory | [Name]
Larotaxel | [CAS]
156294-36-9 | [Synonyms]
XRP9881
Larotaxel
PNU 100940
Larotaxel USP/EP/BP
Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, (1S,2S,4S,7R,8aR,9aS,10aR,12aS,12bR)-7,12a-bis(acetyloxy)-1-(benzoyloxy)-1,3,4,7,8,9,9a,10,10a,12,12a,12b-dodecahydro-2-hydroxy-5,13,13-trimethyl-8-oxo-2,6-methano-2H-cyclodeca[3,4]cyclopropa[4,5]benz[1,2-b]oxet-4-yl ester, (... | [Molecular Formula]
C45H53NO14 | [MDL Number]
MFCD00925691 | [MOL File]
156294-36-9.mol | [Molecular Weight]
831.9 |
| Chemical Properties | Back Directory | [Melting point ]
170 - 174°C (dec.) | [Boiling point ]
889.3±65.0 °C(Predicted) | [density ]
1.37 | [storage temp. ]
-20°C Freezer | [solubility ]
Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
11.20±0.46(Predicted) | [color ]
White to Off-White |
| Hazard Information | Back Directory | [Uses]
Larotaxel (RPR 109881A) is a taxane analog with a broad spectrum of activity and different toxicity profile and with the possible advantages of surpassing some mechanisms of resistance and penetrating into the CNS. | [storage]
Store at -20°C |
|
|